ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/11/2026
Back to search
Official data from USPTO
CENTREXION THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CENTREXION THERAPEUTICS
ST13
US500000087684482Class
5
Filing
87684482
Registration
6622788
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
03/12/2026
Trademark type
Word
Nice classes
5
Filing date
11/14/2017
Registration date
01/18/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/18/2022
Last transaction
03/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/12/2021
First use in commerce
05/12/2021
Drawing code
4
Owner type
03
Owner location
Boston, MA, US
Examiner
ORNDORFF, LINDA
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
C. C. (pessoa física)
Representatives
Glenn A. Gundersen Dechert LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use by humans in the fields of pain reliefpreventionmanagementtreatment
Publications
History of USPTO decisions and trademark events.
45 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/18/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/11/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/10/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/09/2021
IUAF
USE AMENDMENT FILED
12/03/2021
EISU
TEAS STATEMENT OF USE RECEIVED
12/03/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/11/2021
EX5G
SOU EXTENSION 5 GRANTED
06/10/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/10/2021
EXT5
SOU EXTENSION 5 FILED
06/04/2021
EEXT
SOU TEAS EXTENSION RECEIVED
06/04/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/04/2020
EX4G
SOU EXTENSION 4 GRANTED
12/02/2020
EXT4
SOU EXTENSION 4 FILED
12/02/2020
EEXT
SOU TEAS EXTENSION RECEIVED
12/02/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/05/2020
EX3G
SOU EXTENSION 3 GRANTED
06/03/2020
EXT3
SOU EXTENSION 3 FILED
06/03/2020
EEXT
SOU TEAS EXTENSION RECEIVED
06/03/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/26/2019
EX2G
SOU EXTENSION 2 GRANTED
11/22/2019
EXT2
SOU EXTENSION 2 FILED
11/22/2019
EEXT
SOU TEAS EXTENSION RECEIVED
11/22/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/01/2019
EX1G
SOU EXTENSION 1 GRANTED
05/30/2019
EXT1
SOU EXTENSION 1 FILED
05/30/2019
EEXT
SOU TEAS EXTENSION RECEIVED
05/30/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/04/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/09/2018
PUBO
PUBLISHED FOR OPPOSITION
10/09/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/19/2018
ALIE
ASSIGNED TO LIE
09/04/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/20/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/16/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/15/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/15/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/09/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/09/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/28/2018
GNRT
NON-FINAL ACTION E-MAILED
02/28/2018
CNRT
NON-FINAL ACTION WRITTEN
02/28/2018
DOCK
ASSIGNED TO EXAMINER
02/27/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/27/2017
NWAP
NEW APPLICATION ENTERED
11/17/2017
Continuous trademark protection
Get notified about every new filing that threatens CENTREXION THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.